(R)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol, 98%, 100g

1,3-Dichloro-2-chloromethyl-benzene, 97.0%, 25g

N-(Azetidin-3-yl)-2,2,2-trifluoroacetamide hydrochloride, 97%, 100mg

3-Amino-5-methylpyrazin-2(1H)-one, 95+%, 100mg

1-butyryl-4-piperidinone, 95.0%, 5g

(11bR)-4-mercapto-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'f][1,3,2]dioxaphosphepin, 98%, 250mg

2-(2-BROMO-ETHYL)-[1,2]OXAZINANE, 95.0%, 5g

2-Ethyl-5(6)-methylpyrazine, 95.0%, 500g

3,4-Difluorotoluene>98.0%(GC)1g

(2E)-1-(4-nitrophenyl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

2-(Chloromethyl)quinazoline, 95.0%, 100mg

5-Chloro-1H-indol-6-amine, 95.0%, 500mg

(1-Isopropyl-1H-benzimidazol-2-yl)methanol, 95.0%, 1g